发明名称 |
Crystalline [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl |
摘要 |
The specification describes crystalline [R-(R*,R*)]-2-(4-fluorophenyl)- beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4 [(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt designated Form I. The compound also known as atorvastatin is characterized by its X-ray powder diffraction and/or solid state NMR. Also described are methods for the preparation and pharmaceutical composition of the same. The compounds are useful as agents for treating hyperlipidemia and hypercholesterolemia.
|
申请公布号 |
NZ312907(A) |
申请公布日期 |
2000.12.22 |
申请号 |
NZ19960312907 |
申请日期 |
1996.07.08 |
申请人 |
WARNER-LAMBERT COMPANY |
发明人 |
BRIGGS, CHRISTOPHER A;JENNINGS, REX ALLEN;WADE, ROBERT A;HARASAWA, KIKUKO;ICHIKAWA, SHIGERU;MINOHARA, KAZUO;NAKAGAWA, SHINSUKE |
分类号 |
C07D207/34;A61K31/40;A61P3/06;A61P3/14;A61P43/00;C07D;(IPC1-7):A61K31/40 |
主分类号 |
C07D207/34 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|